advanced refractory solid tumors
Showing 1 - 9 of 9
Advanced Refractory Solid Tumors Trial in Tainan, Taipei (T-1101 (Tosylate))
Completed
- Advanced Refractory Solid Tumors
- T-1101 (Tosylate)
-
Taichung City, Taiwan
- +3 more
Nov 17, 2022
Advanced Refractory Solid Tumors Trial in China (Hypofractionated radiotherapy, PD-1 inhibitor, GM-CSF)
Recruiting
- Advanced Refractory Solid Tumors
- Hypofractionated radiotherapy
- +3 more
-
Beijing, China
- +15 more
Aug 8, 2022
Advanced Refractory Solid Tumors Trial in Kaohsiung, Tainan (T-1101 (Tosylate))
Recruiting
- Advanced Refractory Solid Tumors
- T-1101 (Tosylate)
-
Kaohsiung, Taiwan
- +1 more
Oct 31, 2021
Advanced Refractory Solid Tumors, Advanced Triple Negative Breast Cancers, Metastatic Triple Negative Breast Cancers Trial in
Recruiting
- Advanced Refractory Solid Tumors
- +2 more
-
Singapore, SingaporeNational University Hospital
Aug 31, 2021
Advanced Refractory Solid Tumors Trial in Tainan, Taipei (T-1101 (Tosylate))
Terminated
- Advanced Refractory Solid Tumors
- T-1101 (Tosylate)
-
Tainan, Taiwan
- +2 more
Apr 14, 2021
Advanced Refractory Solid Tumors Trial in Kurralta Park (CS1001, Regorafenib)
Recruiting
- Advanced Refractory Solid Tumors
-
Kurralta Park, South Australia, AustraliaAshford Cancer Centre Research
Sep 23, 2020
Advanced Refractory Solid Tumors Trial in Goyang-si (NOV120401)
Unknown status
- Advanced Refractory Solid Tumors
-
Goyang-si, Gyeonggi-do, Korea, Republic ofNational Cancer Center
Aug 13, 2015